Serum Sulfhydryl Determinations and Significance in Connective Tissue Diseases
Authors: ARTHUR LORBER
Journal: Annals of Internal Medicine (1964)

Article1 September 1964Serum Sulfhydryl Determinations and Significance in Connective Tissue DiseasesARTHUR LORBER, M.D., CARL M. PEARSON, M.D., F.A.C.P., WROTHER L. MEREDITH, B.A., LOUISE E. GANTZ-MANDELL, B.A.ARTHUR LORBER, M.D.Search for more papers by this author, CARL M. PEARSON, M.D., F.A.C.P.Search for more papers by this author, WROTHER L. MEREDITH, B.A.Search for more papers by this author, LOUISE E. GANTZ-MANDELL, B.A.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-61-3-423 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSulfhydryl (SH) groups are chemically reactive sites located on protein molecules. Oxidation of these groups results in the formation of disulfide bonds (S-S) (1), thereby interlinking the protein molecules and forming macroglobulins. These serum macroglobulins may be dissociated into their protein subunits by thiol (sulfhydryl-containing) compounds that have the ability to break the disulfide bonds (2-5). The importance of sulfhydryl groups in the formation of macroglobulins is further implied by the virtual absence of these groups in the abnormal protein found in Waldenstrom's macroglobulinemia (2) and by the decreased serum sulfhydryl levels reported in other related neoplastic disorders (6).Rheumatoid...References1. WERTHEIM E: Textbook of Organic Chemistry. The Blakiston Company, Philadelphia, 1945, p. 731. Google Scholar2. BLOCHPRASADANATASIBRIGGS HSAADR: Serum protein changes during administration of a low molecular weight thiol (penicillamine). J. Lab. Clin. Med. 56: 212, 1960. Google Scholar3. DEUTSCHMORTON HFJI: Dissociation of human serum macroglobulins. Science 125: 600, 1957. CrossrefMedlineGoogle Scholar4. DEUTSCHMORTON HFJI: Human serum macroglobulins and dissociation units. I. Physico-chemical properties. J. Biol. Chem. 231: 1107, 1958. CrossrefMedlineGoogle Scholar5. PUTNAM FW: Abnormal human serum globulins. Arch. Biochem. 79: 67, 1959. CrossrefGoogle Scholar6. SCHOENBACHWEISSMANARMISTEAD EBNEB: The determination of sulfhydryl groups in serum. II. Protein alterations associated with disease. J. Clin. Invest. 30: 762, 1951. CrossrefMedlineGoogle Scholar7. KUNKEL HG: Studies on the isolation and characterization of the "rheumatoid factor." J. Clin. Invest. 38: 424, 1959. CrossrefMedlineGoogle Scholar8. PLOTZSINGER CMJM: The latex fixation test: results in rheumatoid arthritis. Amer. J. Med. 21: 893, 1956. CrossrefMedlineGoogle Scholar9. ROTHERMICHPHILIPS NOVK: The serological diagnosis of rheumatoid arthritis. JAMA 164: 1999, 1957. CrossrefMedlineGoogle Scholar10. THOMASROBINSONGOFTONSTUCKEYLAMONT-HAVERS JWHSJPMR: The latex fixation test in rheumatoid arthritis. Canad. Med. Ass. J. 76: 621, 1957. MedlineGoogle Scholar11. BENESCHLARDYBENESCH REHAR: The sulfhydryl groups of crystalline proteins. J. Biol. Chem. 216, 663, 1955. CrossrefMedlineGoogle Scholar12. REINHOLD JG: Total protein, albumin, and globulin, in Standard Methods of Clinical Chemistry, edited by REINER, M., Academic Press, Inc., New York, 1963, Vol. 1, p. 88. Google Scholar13. SINGERPLOTZ JMCM: The latex fixation test: application to the serological diagnosis of rheumatoid arthritis. Amer. J. Med. 21: 888, 1956. CrossrefMedlineGoogle Scholar14. JAHNKESCHOLTANHEINZLER KWF: Die visiositat von Serum und isolierten Serum-proteinen bei Makroglobulinamien und anderen Dysund Paraproteinamien. Helv. Med. Acta 25: 2, 1958. MedlineGoogle Scholar15. KUNKEL HG: Macroglobulins and high molecular weight antibodies, in The Plasma Proteins, edited by PUTNAM, F. W., Academic Press, Inc., New York, 1960, Vol. 1, p. 299. CrossrefGoogle Scholar16. Ibid., pp. 302 and 305. Google Scholar17. BAUMSTASTNYZIFF JPM: Effects of the rheumatoid factor and antigen-antibody complexes on the vessels of the rat mesentery. Arthritis Rheum. 5: 101, 1962. Google Scholar18. MCCORMICK JN: An immunofluorescence study of rheumatoid factor. Ann. Rheum. Dis. 22: 1, 1963. CrossrefMedlineGoogle Scholar19. MELLORSNOWOSLAWSKIKORNGOLD RCAL: Rheumatoid arthritis and the cellular origin of rheumatoid factors. Amer. J. Path. 39: 533, 1961. MedlineGoogle Scholar20. MELLORSNOWOSLAWSKIKORNGOLDSENGSON RCALBL: Rheumatoid factor and the pathogenesis of rheumatoid arthritis. J. Exp. Med. 113: 475, 1961. CrossrefMedlineGoogle Scholar21. BALL J: Observations on the presence of rheumatoid serum factor in skin and other tissues. Ann. Rheum. Dis. 21: 272, 1962. CrossrefMedlineGoogle Scholar22. BLANDCLARK JHG: Rheumatoid factor in serum and synovial fluid. Arthritis Rheum. 5: 102, 1962. Google Scholar23. RODNANEISENBEISCRIEGHTON CPCHAS: On the occurrence of rheumatoid factor in synovial fluid. Arthritis Rheum. 5: 316, 1962. Google Scholar24. EDELMANKUNKELFRANKLIN GMHGEC: Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J. Exp. Med. 108: 105, 1958. CrossrefMedlineGoogle Scholar25. JANDLENGLEALLEN JHLKDW: Oxodative hemolysis and precipitation of hemoglobin. I. Heinz body anemias as an acceleration of red cell aging. J. Clin. Invest. 39: 1818, 1960. CrossrefMedlineGoogle Scholar26. STEINRAUFDANDLIKER LKWB: A study of the reaction of the disulfide groups of bovine serum albumin during heat denaturation. J. Amer. Chem. Soc. 80: 3833, 1958. CrossrefGoogle Scholar27. LORBER A: Increased globulin fractionation by an improved vertical gel electrophoretic technique. J. Lab. Clin. Med. 64: 133, 1964. MedlineGoogle Scholar28. BOYER PD: Sulfhydryl and disulfide groups of enzymes, in The Enzymes, edited by BOYER, P. D., LARDY, H., MYRBACK, K., Academic Press Inc., New York, 1959, Vol. 1, p. 511. Google Scholar29. RITZMANNBAUGHANLEVIN SEMAWC: In vivo reduction of cold agglutinins by B6-SH. Clin. Res. 11: 34, 1963. Google Scholar30. JAFFE IA: In vivo dissociation of the rheumatoid factor. Arthritis Rheum. 1: 122, 1962. Google Scholar31. JAFFE I: A comparison of the effects of penicillamine and plasmapheresis on the serum. Ann. Rheum. Dis. 22: 71, 1963. CrossrefMedlineGoogle Scholar32. DEUTSCHCHAN HFPC: Human serum hemagglutinins. Fed. Proc. 17: 210, 1958. Google Scholar33. FUDENBERGKUNKEL HHHG: Physical properties of the red cell agglutinins in acquired hemolytic anemia. J. Exp. Med. 106: 689, 1957. CrossrefMedlineGoogle Scholar34. GLENCHURZINNEMANBRIGGS HHHDR: Macroglobulinemia: report of two cases. Arch. Intern. Med. (Chicago) 48: 1055, 1958. LinkGoogle Scholar35. EDELMANNPOULIK GMMD: Studies on structural units of the gamma-globulins. J. Exp. Med. 113: 861, 1961. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Los Angeles, CaliforniaFrom the Departments of Medicine, Wadsworth Veterans Administration Hospital, Sepulveda Veterans Administration Hospital, and the University of California Medical Center, Los Angeles, Calif.This study was supported in part by a grant from the Southern California Chapter of the Arthritis and Rheumatism Association.Request for reprints should be addressed to Arthur Lorber, M.D., Veterans Administration Hospital, Sepulveda, Calif. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSFDecreased Serum Sulphydryl Levels as a Sign of Increased Oxidative Stress in Generalized Anxiety DisorderEffects of antirheumatic drugs on protein sulphydryl reactivity of human serumInhibition of Human Platelet Aggregation by Diazeniumdiolates: Extent of Inhibition Correlates with Nitric Oxide Load DeliveredEnhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodiesEvidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patientsIncreased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosusAntioxidant status in rheumatoid arthritis and role of antioxidant therapyRegulation by interferon β-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patientsThe Role of Prooxidant—Antioxidant Imbalances in the Pathogenesis of Rheumatoid Arthritis[41] Measurement of protein thiol groups and glutathione in plasmaGold ion induces contraction in frog skeletal muscle fibersModulation of human T cell functions by surface sulphydryl groups: differential effects on IL-2 production and responsivenessHomocysteine uptake by human umbilical vein endothelial cells in cultureControl of Oxidative Damage in Rheumatoid Arthritis By Gold(I)-Thiolate DrugsInhibition of Several Enzymes by Gold Compounds II. β-Glucuronidase, Acid Phosphatase and L-Malate Dehydrogenase by Sodium Thiomalatoraurate (I), Sodium Thiosulfatoaurate (I) and Thioglucosoaurate (I)Biochemical markers of disease activityThe pharmacology and biochemical action of second-line agentsSlow Acting AntirheumaticsThe role of IgA in the immunopathogenesis of rheumatoid arthritisSuperoxide dependent iron release from ferritin in inflammatory diseasesLuminol dependent chemiluminescence and thiol group oxidation provoked by neutrophils is attributable to different oxidizing speciesMethodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systemsSerum and synovial fluid histidine: a comparison in rheumatoid arthritis and osteoarthritisIntracellular and extracellular sulphydryl levels in rheumatoid arthritis.Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasmaIgA dysfunction in rheumatoid arthritisTransport of cystine and cysteine in mammalian cellsThe oxidation of serum sulph-hydryl groups by hydrogen peroxide secreted by stimulated phagocytic cells in rheumatoid arthritisAn improved method of determination of SH group concentration and reactivity in plasma of patients with various clinical disorders and in rats after administration of indomethacin or carbon tetrachlorideSerum biochemistry in relation to the action of azathioprine in rheumatoid arthritisDrug therapy (3): ‘specific’ drugsBiochemical and clinical changes in rheumatoid arthritis: Their relation to the action of antirheumatoid drugsCopper, Free Radicals and Rheumatoid ArthritisAltered thiol status in patients with rheumatoid arthritis1 Immunopharmacology of GoldChanges in the binding of copper in the plasma of molybdenum supplemented ratsSulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalateSerum Sulfhydryl Levels in Rheumatoid Patients Treated with CyclophosphamideMode of Action of Anti-Inflammatory Agents Which are Prostaglandin Synthetase InhibitorsDetermination of cysteine in plasma and urine and homocysteine in plasma by high-pressure liquid chromatographyFenclofenac in Rheumatoid Arthritis: Sequential Double-blind Cross-over Comparisons with Placebo and NaproxenSerum Sulphydryl Changes in Rheumatoid Coalworkers’ Pneumoconiosis Patients Treated with D-penicillamineModulation of the Expression of the Immune Response by Antiinflammatory DrugsD-Penicillamine in Rheumatoid ArthritisSerum protein changes in coal workers' pneumoconiosisSerum sulphydryl levels in rheumatoid patients treated with alclofenacDesign and Laboratory Evaluation of Gold Compounds as Antiinflammatory AgentsMolecular and Cellular Pharmacology of the Antiinflammatory Drugs: Some in Vitro Properties Related to Their Possible Modes of ActionPorphyria: Theories of Etiology and TreatmentNon-specific humoural immunity response in latent and tertiary syphilis.PLASMA GOLD ESTIMATIONS IN PATIENTS RECEIVING CHRYSOTHERAPY FOR RHEUMATOID ARTHRITISSulfhydryl deficiency in connective tissue disorders: Correlation with disease activity and protein alterationsEffect of thiols in biological systems on protein sulfhydryl contentD-Penicillamine in rheumatoid arthritisSeveral Pharmacologic and Biochemical Aspects of Cysteamine- and Cystamine-Induced ShockSerum copper levels in rheumatoid arthritis:Rheumatoid arthritis with secondary amyloidosis and malabsorption syndromeGlycosaminoglycans in Joint DisordersEffect of increased serum sulphydryl content on titre of rheumatoid factor.Primary macroglobulinemiaThe reduction of experimentally induced inflammation by sulfhydryl compoundsInfluence De L'Injection De Cystamine Et De Divers États De Choc Sur Les Protéines Plasmatiques Du Rat, Du Lapin Et Du PouletPenicillamine Therapy for Rheumatoid Lung Disease: Effects on Protein Sulphydryl GroupsThe effect of penicillamine on the laboratory parameters in rheumatoid arthritisFatal polyarteritis presenting as asymmetrical peripheral gangrene. 1 September 1964Volume 61, Issue 3Page: 423-434KeywordsArthritisAttentionHospital medicineLatexOsteoarthritisPathogensProteinsSerum proteinsSpondylitisVasculitis Issue Published: 1 September 1964 PDF DownloadLoading ...